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Background: Obesity increases the risk for knee and hip joint implantation and negatively contributes to wound
healing. In this study, in 52 patients undergoing hip and knee arthroplasty the amount of peripheral immune
effector cells pre- and post-operative, as well as the expression of certain soluble factors affecting the functions of
immune effector cells were investigated.
Methods: The peripheral immune cells and the expression of the soluble factors were determined by flow
cytometry and correlated to each other in dependency of the BMI, the sex, and the kind of arthroplasty.
Results: The pre-operative amounts of peripheral NK cells and cytotoxic T cells significantly decreased with
increasing BMI. Furthermore, the expression of the immunomodulatory adipokine leptin nicely correlated to the
BMI. These effects were stronger in males than in females. Furthermore, the correlation of the activation marker
sTNF-R and peripheral T cells strongly decreased with increasing BMI. While IL-6, CD40L, and MPO were significantly
induced after surgery, there were no correlations to the BMI.
Conclusions: The known wound-healing problems in obese patients and the osteoarthritis per se can be linked to
the BMI. While obese patients exerted reduced peripheral NK cells and cytotoxic T cells (CTLs), IL-6 showed no
involvement. However, the adipokine leptin strongly increased with the BMI strengthening its role as
immunomodulatory molecule negatively interfering the functions of immune effector cells.
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Overweight (body mass index (BMI) ≥25 kg/m2) and
obesity (BMI ≥ 30 kg/m2) strongly increase among the
western world population [1]. Indeed, recent studies
demonstrated the correlation between obesity and the
prevalence of the arthrosis mediated need for an artifi-
cial hip and knee joint implantation [2]. Furthermore, it
could be demonstrated that obesity is linked with post-
operative wound healing complications of hip and knee
arthroplasty [3]. Also, a significant correlation of obesity
and the expression of TNF-α, CRP, and IL-6 has been
described in literature [4]. In the last decades, the num-
ber of total hip and knee replacements increased* Correspondence: simon.jasinski@uk-halle.de
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White adipose tissue, mainly composed of adipocytes, is
not only an energy reservoir or a protective envelope
located subcutaneously and around the internal organs (vis-
ceral adipose tissue), it further secretes certain cytokines,
so-called adipokines, involved in important biological pro-
cesses including immunology and metabolism [5].
Adipokines can exert anti- and pro-inflammatory
effects. Leptin is the most important immunoregulatory
adipokine. Apart from its T-lymphocyte modulating role
[6], it also inhibits the proliferation of monocytes and
macrophages and enhances their cytokine secretion [7, 8].
Our group could demonstrate that natural killer (NK) cells
express the functional isoform of the leptin receptor (Ob-
Rb) [9] and a short-term stimulation of NK cells withle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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and tumor cell lysis [10]. Obese individuals have highly
elevated serum adipokine and cytokine levels—a so-called
chronic low-grade inflammation. Thus, a long-term incu-
bation of NK cells with leptin (as seen in obese individ-
uals) impairs the anti-tumoral NK cell functions [10], an
interesting point, because obesity increases the risk for
certain tumor diseases, like colorectal cancer, renal cancer,
post-menopausal breast cancer, and prostate cancer [1].
The most highly expressed mRNA in adipocytes of normal
weight individuals is the one of the anti-inflammatory adi-
pokines, the adiponectin [11]. Adiponectin is inversely
correlated to plasma CRP levels [12]. Furthermore, adipo-
nectin production in adipocytes is inhibited by the
pro-inflammatory cytokines tumor necrosis factor (TNF)-
α and interleukin (IL)-6 [13], which are also produced in
fat tissue next to resistin, visfatin and many others.
To investigate the link between obesity and the im-
mune status in regard of known wound-healing prob-
lems in patients undergoing primary hip and knee
arthroplasty pre- and post-operatively, acquired blood
samples were investigated and analyzed for immune
effector cells, selected adipokines, and certain clinical
markers. The results were compared between pre- vs.
post-operative status, hip vs. knee joint implantation,




The study population includes 52 volunteers (25 males
and 27 females) aged between 40 and 80 years. These
volunteers were patients in the Department for Orthope-
dics, Trauma and Reconstructive Surgery, University
Hospital, Halle (Saale), Germany receiving a primary hip
or knee joint implantation. From the males, 10 patients
received a total knee arthroplasty and 15 patients
received a total hip replacement, while from the female
group, 16 patients received a knee and 11 patients
received a hip implantation.
The study population was further subdivided according
to the body mass index (BMI) into the following groups:
normal weight (BMI <25 kg/m2), overweight (25 kg/m2 ≤
BMI< 30 kg/m2), and obese (BMI ≥30 kg/m2). For anTable 1 Overview of the patients who participated in this study
Male
Subdivision by weight Normal weight Overweight Obese




n = 10 (63 years) n = 15 (69 years)
Total n = 52 (67 years)
Mean age in bracketsexact summary of the subdivisions of the study population
and the respective age, please see Table 1.
Exclusion criteria were denial of the declaration of con-
sent, non-joint-related proven centers of infection
(chronic or acute), known metabolic or endocrine diseases
(e.g., diabetes mellitus type I, hypo- or hyper-thyreoses),
and immune suppression (congenital or acquired).
This study followed the Declaration of Helsinki and was
approved by the local ethics committee of the Faculty of
Medicine, Martin Luther University Halle-Wittenberg,
Halle (Saale), Germany.
Sample collection and preparation
Fasting blood samples were collected routinely pre-
(3 ± 2 days) and post-operatively (5 ± 2 days). From
each donor, 2.7 ml of heparinized blood was used for
further analyses. Quantification of CRP and leukocytes
was also performed routinely.
Flow cytometry
To determine and quantify various immune effector cell
populations (CD3− CD20+ B cells; T cells including CD3
+ CD4+ T helper cells and CD3+ CD8+ cytotoxic T cells;
CD3+ CD56+ NKT cells and CD3− CD56+ NK cells) in
the blood samples, flow cytometry was performed at a
LSRFortessa unit (Becton Dickinson, BD, Franklin Lakes,
NJ, USA). The following murine monoclonal antibodies
were applied: PE-Cy7 anti-human CD3 [UCHT1] (BD),
APC anti-human CD4 [L200] (BD), PE anti-human CD8
[HIT8a] (BD), APC-H7 anti-human CD20 [2H7] (BD),
and APC anti-human CD56 [NCAM16.2] (BD). Prior to
this, the erythrocytes were removed by hypotonic lysis.
Cytokine analysis
Cytokines and soluble factors were determined by usage
of the FlowCytomix human obesity 9plex kit (eBioscience,
San Diego, CA, USA) according to the manufacturers’
protocol. This kit allows an antibody-based detection and
quantification of soluble CD40L, soluble ICAM1, IL-6,
Leptin, MCP-1, MPO, OPG, resistin, and soluble TNF-R.
After incubating the serum with the respective capture
antibodies linked to beads, a biotinylated second antibody
was added. In the last step, PE labeled streptavidin was
added for emitting the fluorescent signal. The respectiveFemale
Normal weight Overweight Obese
69 years) n = 7 (71 years) n = 9 (67 years) n = 11 (67 years)
Knee Hip
n = 16 (69 years) n = 11 (68 years)
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standards for each target.
Statistical analyses
Microsoft Excel 2010 (Microsoft Corporation) and SPSS
16.0 (IBM) were used to calculate mean and standard deriv-
ation or to perform the t test. For the two-sided t test, un-
equal variances have been selected and Levene’s test was
performed. Significance was assigned when p < 0.05 and
marked with a star (or if lower than 0.005 with two stars).
Results
Comparison of the pre- and post-operative immune sta-
tus of patients undergoing hip and knee arthroplasty
A statistical significant decrease of NK cells (p < 0.005)
after the surgical intervention (Fig. 1a) could be detected.Fig. 1 Pre- and post-operative comparative analysis of immunological para
amount of peripheral immune effector cells in the blood samples of 52 pa
post-operatively by flow cytometry. While NK cells were statistically signific
From further analyses of Th cells, CTLs and NKT cells can be concluded tha
differential expression of several soluble factors was pre- and post-operativ
and the usage of the FlowCytomix human obesity 9plex kit (eBioscience) r
IL-6, sTNF-R, sCD40L, and MPO after surgeryFurthermore, a significant increase of peripheral T cells
(p < 0.05) was observed post-operatively, most likely caused
by an increase of T helper (Th) cells, since a decreased
amount of cytotoxic T cell (CTL) and not affected NKT
cells were measured (Fig. 1a). Additionally, no differences
in the presence of B cells and leukocytes were detected.
In addition to the analysis of the lymphocyte subsets,
also the expression of certain immunological relevant
molecules including adipokines was determined. The
CRP levels increased statistically significant (more than
26 times; p < 0.005; Fig. 1b) after the surgical procedure.
Also, the pro-inflammatory cytokine IL-6 was signifi-
cantly increased (about four times; p < 0.005; Fig. 1b). As
part of the post-operative status of immune activation,
sTNF-R was also significantly increased (p < 0.005).
Finally, also the levels of sCD40L (p < 0.05) andmeters in patients undergoing hip and knee arthroplasty. a The
tients receiving hip and knee arthroplasty were determined pre- and
antly reduced after surgery, the T cells were significantly increased.
t this induction is mainly caused by an increase of Th cells. b The
ely determined in the blood samples of 52 patients by flow cytometry
evealing a statistically significant induction in the serum level of CRP,
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hanced after the surgical intervention. However, this in-
crease was very modest (sCD40L: 1.74 times and MPO:
1.17 times). Other measured parameters showed no sig-
nificant differences in their expression pattern when
comparing the pre- and post-operative status (Fig. 1b).
Differential amounts of peripheral immune effector cells
in dependency of patient parameters
No differences could be observed when comparing B
and NKT cells pre- vs. post-operatively, male vs. female,Fig. 2 Pre- and post-operative immunoscoring of selected peripheral immu
determined immune effector cells in the blood samples of the 52 patients
body weight, sex, and kind of arthroplasty. The values are expressed in % o
values are expressed in % of the NK cells. a The amount of peripheral Th cells in
b In the pre-operative condition, the amount of CTLs was statistically significant
This effect could not be observed directly after surgery. c In the pre-operative p
males and females. These effects were only statistically significant in males. d Th
male vs. females and knee vs. hip joint implants, the NK cells were significantly r
the BMI in males and females. However, these effects were weak and not statist
significant higher levels of CD56dim NK cells than females (f), but for CD56bright Nknee vs. hip joint implantation, or normal weight vs.
overweight vs. obese. Contrary to that, Th cells were
determined at a higher percentage in the blood samples
of overweight and obese patients when compared to the
normal weight patients. This effect could be observed
pre- and post-operatively. However, the differences were
not statistically significant (Fig. 2a).
On the other hand, the pre-operative CTLs were sta-
tistically significantly decreased in obese patients as
compared to normal weight patients (Fig. 2b). Interest-
ingly, this effect was more pronounced in males than inne effector cells in relation to the body weight. The results of the
by flow cytometry were correlated with certain parameters including
f the PBMCs, and in the case of CD56bright and CD56dim NK cells, the
creased with the BMI in males and females, but not statistically significant.
ly reduced in obese patients, when compared to normal weight patients.
hase, the number of peripheral CTLs negatively correlated to the BMI in
e by far strongest effects were determined for NK cells. In the constellations
educed after surgery. e The number of peripheral NK cells decreased with
ically significant. Interestingly, in the pre-operative phase, males had
K cells, it was the other way around (g)
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peripheral CTLs could be observed in the other
comparisons.
The by far strongest differences could be detected in
the quantities of peripheral NK cells. While male
patients showed the highest presence of peripheral NK
cells pre- and post-operatively, no differences were
observed when comparing knee vs. hip joint implanta-
tions. All differences concerning the number of periph-
eral NK cells in pre- and post-operative groups were
statistically significant, demonstrating the general effect
of the post-operative decline of peripheral NK cells and
herewith an impairment of one part of the innate
immune system (Fig. 2d).
In analogy to the pre-operative status of CTLs, also
the pre-operative NK cells were decreased in obese pa-
tients when compared to normal weight patients both in
males and females. However, the difference failed to
reach statistical significance (Fig. 2e).
As already mentioned, numbers of peripheral NK cells
were higher in males as compared to females. Further
investigations demonstrated that these NK cells were
NK cells with a low expression of CD56 (CD56dim).
Interestingly, numbers of CD56bright NK cells were sig-
nificantly higher in females than in males (Fig. 2f, g).
While CD56dim NK cells represent 90% of the peripheral
blood NK cells and reveal a higher cytotoxicity, the
CD56bright NK cells are more efficient cytokine pro-
ducers like IFN-γ.Fig. 3 Correlation between CRP levels and BMI in females and males. The
and knee arthroplasty routinely pre- and post-operative. a–c In the pre-ope
However, this effect was just observed in females, but not for males. This e
level per se (d–f)Correlation between CRP level and BMI in females
The acute-phase reactant CRP is a marker for inflamma-
tion and is induced by IL-6. CRP and IL-6 are pro-
inflammatory mediators secreted among others by
adipose tissue. Therefore, the pre- and post-operative
plasma level of CRP was correlated with the BMI of the
patients. In females, the pre-operative plasma level of
CRP tends to correlate with the BMI, while in males, no
correlation could be detected (Fig. 3a–c).
The post-operative CRP plasma levels dramatically in-
creased in all patients due to surgery when compared to
the pre-operative status (p < 0.05). No further correlation
to the BMI could be observed after surgery (Fig. 3d–f ).
BMI-linked leptin expression correlates strongest in knee
joint implantations and in males
The expression of leptin nicely correlated to the BMI. This
correlation was stronger in knee joint implantations than in
hip joint implantations (pre- and post-operative; Fig. 4a–d).
Furthermore, the correlation between leptin expres-
sion and BMI was stronger in males than in females
(pre- and post-operative; Fig. 4e–h). The other deter-
mined soluble factors were also correlated to the BMI,
and the results are summarized in Table 2.
Correlation between peripheral T cells and sTNF-R expres-
sion in dependence of the BMI
Figure 2c demonstrates a decreasing amount of periph-
eral CTLs with increasing BMI of the patients. ThisCRP levels were determined in the blood samples of 52 patients of hip
rative phase, there was a correlation between CRP levels and the BMI.
ffect was lost directly after surgery due to the massive increase of CRP
Fig. 4 BMI-linked leptin expression. a–h The leptin serum levels of the 52 patients were correlated to the BMI in dependency of the kind of performed
arthroplasty and in dependency of the sex. The leptin expression levels correlated nicely to the BMI pre- and post-operatively. However, the effect was
stronger in knee joint implantation than in hip joint implantation and was stronger in males when compared to females
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in males. Furthermore, Fig. 1b shows a significant increase
of the expression of the early inflammation marker sTNF-
R after the surgical procedures. It was also the question
addressed whether the sTNF-R expression shows any
correlation with the BMI. Indeed, from normal weight to
overweight to obese, the correlation between post-
operative peripheral T cells and sTNF-R expression
dramatically decreases (Fig. 5a–c), which can be explained
by a declining T cell activity with an increasing BMI.
Discussion
In this study, the pre- and post-operative immune status
with a special focus on the BMI of patients receivingknee and hip arthroplasty was investigated. Indeed, the
post-operative peripheral NK cells were statistically
significantly (p < 0.005) reduced when compared to the
pre-operative status. The cytokines IL-15 and IL-2 can
induce proliferation in NK cells [14]. While IL-2 is
mainly expressed in Th cells, IL-15 is constitutively
expressed by certain immune cell populations including
monocytes, macrophages, and dendritic cells [15]. In the
blood, circulating monocytes are recruited to inflamed
tissues and can derive to macrophages or dendritic cells
[16]. The removal of the inflammatory site due to the
arthroplasty could therefore explain the post-operative
reduction of peripheral NK cells. Another in general
explanation for that effect has been described as
Table 2 The expression of determined soluble factors in dependency of the BMI in the blood sera of the patients
Pre-
operative 








































BMI 0.1282 0.0011 0.0585 0.0001 0.1982 0.0171 0.0284 0.0065 0.0301
Leptin 
vs. BMI 0.396 0.4294 0.1201 0.2928 0.3571 0.4679 0.2205 0.2902 0.5878
sCD40L 
vs.BMI 0.0274 0.0511 0.0001 0.0671 0.057 0.0908 0.0424 0.0252 0.0064
sTNF-R 
vs. BMI 0.0118 0.0395 0.0433 0.2058 0.0391 0.3743 0.0181 0.0331 0.1685
sICAM1 
vs. BMI 0.0129 0.0858 0.0036 0.0047 0.0451 0.0005 0.0395 0.0458 0.6372
OPG 
vs. BMI 0.0535 0.0209 0.0691 0.0072 0.1085 0.0039 0.027 0.0253 0.1525
MPO 
vs. BMI 0.0154 0.0188 0.0017 0.0345 0.0001 0.0486 0.0054 0.0347 0.0125
MCP-1 
vs. BMI 0.0152 0.0337 0.00004 0.1008 0.0002 0.0002 0.006 0.1055 0.5038
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leading to a downregulation of Th cells, cytotoxic T cells
(CTLs), and natural killer cells [17].
In contrast to that, a modest but statistically significant
(p < 0.05) post-operative increase of peripheral T cells
was detected; while CTLs and NKT cells were downreg-
ulated, the Th cells were induced. However, the reported
effect of suppression of cellular immunity after surgical
stress [17] has been reported for until at least 2 weeks
post-operatively. In this study, the post-operative blood
samples were taken 5 ± 2 days after surgery.
The post-operative increase of T cells would also
explain the detected post-operative-enhanced secretion
of IL-6, which is among others secreted by T cells [18],
and the soluble form of CD40L, which is shed from the
surface of activated T cells [19].
Analysis of peripheral blood lymphocyte subsets has
become an essential tool in the evaluation of immuno-
logical and pathological disorders. By analyzing the com-
position of the immune effector cells, it turned out that
the amount of pre-operative peripheral NK cells and
CTLs is declining from normal weight to overweight
and to obese patients. Indeed, that effect was stronger in
males than in females. Males even exerted higherFig. 5 Correlation between post-operative peripheral T cells and sTNF-R ex
serum levels of the activation marker sTNF-R with the amount of peripheraamounts of CTLs and NK cells per se. Such gender-
related differences in the amount of CTLs and NK cells
are in line with the reference values for lymphocyte
subsets in Caucasians [20, 21].
Overweight and obesity increase the formation of
osteoarthritis [22], negatively influence wound-healing
processes [23], and even increase the prevalence of
certain tumor diseases [1]. In prior studies, it was dem-
onstrated that long-term effects of the adipokine leptin
led to immunomodulatory functions on various immune
cells including NK cells [10]. Due to the fact that leptin
expression correlates with the amount of adipose tissue
[24], the immunomodulatory effects of long-term leptin
incubation on immune effector cells could be an explan-
ation for the reduced wound healing in overweight and
obese patients.
Indeed, in this study group, a correlation of leptin
expression and the BMI could be observed. The stron-
gest leptin correlation to the BMI occurred in the
subgroup of males and in the subgroup receiving a knee
joint implantation.
However, literature reports higher physiological
plasma leptin level for women [25], a fact that not
necessarily disagrees with the observation from thispression in dependence of the body weight. a–c The correlation of
l T cells decreased strongly with increasing BMI
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knee arthroplasty. Interestingly, a study with a large co-
hort demonstrated that plasma leptin levels are stronger
linked to a cardiovascular death in males than in females
[26]. Furthermore, it could be shown that high-elevated
leptin levels in obese individuals result in the develop-
ment of a leptin resistance [10].
The data from this study demonstrate for the first time
that numbers of peripheral CTLs and NK cells are
decreased in pre-operative obese patients when com-
pared to normal weight patients suffering from osteo-
arthritis. NK cells usually form 5 to 15% of the
peripheral blood mononuclear cells [27]. A decreased
amount of peripheral NK cells has been reported for
rheumatoid arthritis [28]. Interestingly, in osteoarthritis,
NK cells highly infiltrate the synovial-tissue [29] offering
an explanation for the determined decrease of peripheral
NK cells and CTLs in obese patients with a more dis-
tinct inflammation and worsened wound-healing pro-
cesses per se. It is furthermore noteworthy that in obese
patients, the amount of circulating regulatory T cells is
reduced, a circumstance that promotes inflammational
processes.
Osteoarthritis is simply defined as non-inflammatory
arthritis in comparison to rheumatoid arthritis. However,
this old-fashioned classification has been described as
very unfortunate in the actual literature [30]. Naturally,
osteoarthritis occurs with inflammational processes due
to cartilage and synovial destruction [30] in notable sized
areas (for example hip and knee) when compared to the
sizes of certain tumor diseases. Actual literature defines
osteoarthritis not as one disease but rather a conse-
quence of many predisposing factors like age, joint
trauma, and obesity [30]. Interestingly, most frequently
infiltrating immune effector cells are among other T
cells. However, the absolute number of infiltrating
immune effector cells is lower than in rheumatoid arth-
ritis [31]. Therefore, certain parameters involved in
immune status and wound healing were determined, in-
cluding peripheral immune cells and selected soluble
plasma factors.
The early inflammation marker sTNF-R is produced
for example by activated T cells and is upregulated in
synovial T cells of rheumatoid arthritis patients [32]. In-
deed, in this study, it could be demonstrated that the ex-
pression of sTNF-R in normal weight patients is
correlated to the amount of peripheral T cells. This cor-
relation strongly decreases with increasing BMI, leading
to the hypothesis of impaired functions of peripheral T
cells in obese patients, next to the fact of the reduced
amount of peripheral T cells in obese patients per se.
However, further studies are necessary to determine
such impaired T cell functions in obese humans when
compared to normal weight persons.Conclusions
In dependency of the BMI, a reduced amount of periph-
eral NK cells and CTLs as well as a reduced expression
of activation markers were observed, while the leptin
levels increased with the BMI. This demonstrates some
of the consequences of obesity on the immune system
potentially negatively contributing to known wound-
healing problems in obese patients.
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